Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,794 | 10 | 52.6% |
| Food and Beverage | $11,713 | 551 | 41.6% |
| Travel and Lodging | $1,518 | 8 | 5.4% |
| Education | $118.25 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $12,182 | 21 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,834 | 6 | $0 (2022) |
| Inspire Medical Systems, Inc. | $1,890 | 11 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $956.61 | 36 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $693.65 | 44 | $0 (2024) |
| Biogen, Inc. | $580.28 | 31 | $0 (2020) |
| GENZYME CORPORATION | $553.63 | 31 | $0 (2020) |
| Allergan, Inc. | $542.07 | 39 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $463.23 | 25 | $0 (2020) |
| UCB, Inc. | $454.91 | 26 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.12 | 7 | Inspire Medical Systems, Inc. ($459.93) |
| 2023 | $1,430 | 8 | Inspire Medical Systems, Inc. ($1,430) |
| 2022 | $4,834 | 6 | Biohaven Pharmaceutical Holding Company Ltd. ($4,834) |
| 2021 | $12,135 | 20 | Biohaven Pharmaceuticals, Inc. ($12,135) |
| 2020 | $797.18 | 36 | Jazz Pharmaceuticals Inc. ($140.06) |
| 2019 | $2,911 | 170 | Novartis Pharmaceuticals Corporation ($415.79) |
| 2018 | $2,750 | 159 | Amgen Inc. ($267.68) |
| 2017 | $2,670 | 165 | Bayer HealthCare Pharmaceuticals Inc. ($263.71) |
All Payment Transactions
571 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $105.60 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $94.91 | General |
| Category: NEUROLOGY | ||||||
| 09/10/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROLOGY | ||||||
| 08/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $206.09 | General |
| Category: NEUROLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $158.93 | General |
| Category: NEUROLOGY | ||||||
| 01/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Neurology | ||||||
| 10/25/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $254.82 | General |
| Category: NEUROLOGY | ||||||
| 07/23/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | In-kind items and services | $0.94 | General |
| Category: NEUROLOGY | ||||||
| 07/21/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | In-kind items and services | $2.73 | General |
| Category: NEUROLOGY | ||||||
| 06/18/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | In-kind items and services | $11.79 | General |
| Category: NEUROLOGY | ||||||
| 06/17/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | In-kind items and services | $23.12 | General |
| Category: NEUROLOGY | ||||||
| 06/12/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $489.95 | General |
| Category: NEUROLOGY | ||||||
| 06/12/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Travel and Lodging | In-kind items and services | $457.23 | General |
| Category: NEUROLOGY | ||||||
| 04/12/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $189.51 | General |
| Category: NEUROLOGY | ||||||
| 10/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: PRIMARY CARE | ||||||
| 08/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: PRIMARY CARE | ||||||
| 08/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $106.33 | General |
| Category: PRIMARY CARE | ||||||
| 04/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $83.60 | General |
| Category: PRIMARY CARE | ||||||
| 04/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: PRIMARY CARE | ||||||
| 04/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $121.74 | General |
| Category: PRIMARY CARE | ||||||
| 11/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: PRIMARY CARE | ||||||
| 11/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $110.54 | General |
| Category: PRIMARY CARE | ||||||
| 07/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: PRIMARY CARE | ||||||
| 07/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,100 | 1,225 | $246,594 | $81,307 |
| 2022 | 9 | 1,020 | 1,142 | $234,206 | $82,504 |
| 2021 | 10 | 1,071 | 1,228 | $226,608 | $84,799 |
| 2020 | 9 | 1,111 | 1,342 | $247,839 | $80,503 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 383 | $73,586 | $25,472 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 341 | 377 | $51,272 | $17,879 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 78 | $20,624 | $7,845 | 38.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 79 | 80 | $20,800 | $6,978 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $16,445 | $5,057 | 30.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 44 | 49 | $13,965 | $4,649 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $13,872 | $3,909 | 28.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 73 | 74 | $13,690 | $2,290 | 16.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $5,397 | $2,164 | 40.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 19 | 19 | $4,940 | $1,773 | 35.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 15 | 16 | $4,560 | $1,476 | 32.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,743 | $1,243 | 33.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 20 | 20 | $3,700 | $572.41 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 395 | 492 | $93,480 | $33,831 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 235 | 248 | $32,896 | $12,373 | 37.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 82 | $21,648 | $9,084 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $22,126 | $7,749 | 35.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 47 | 54 | $15,390 | $4,876 | 31.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 58 | 58 | $15,080 | $4,696 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $13,056 | $4,528 | 34.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 18 | 18 | $4,680 | $1,541 | 32.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 38 | 39 | $6,741 | $1,257 | 18.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 11 | 11 | $3,135 | $1,102 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,364 | $747.67 | 31.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 22 | 22 | $3,610 | $720.33 | 20.0% |
About Dr. Patrick Harding, MD
Dr. Patrick Harding, MD is a Neurology healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467424556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Harding, MD has received a total of $28,143 in payments from pharmaceutical and medical device companies, with $616.12 received in 2024. These payments were reported across 571 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,794).
As a Medicare-enrolled provider, Harding has provided services to 4,302 Medicare beneficiaries, totaling 4,937 services with total Medicare billing of $329,113. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Williamsburg, VA
- Active Since 02/03/2006
- Last Updated 06/16/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467424556
Products in Payments
- NURTEC ODT (Drug) $17,016
- INSPIRE (Device) $1,890
- Xyrem (Drug) $452.39
- TECFIDERA (Drug) $417.80
- Aimovig (Biological) $391.27
- TROKENDI XR (Drug) $368.67
- Betaseron (Drug) $366.58
- LEMTRADA (Drug) $356.87
- ACTHAR (Biological) $342.66
- VNS Therapy (Device) $333.46
- OCREVUS (Biological) $312.36
- GILENYA (Drug) $274.41
- Rebif (Biological) $271.90
- SOLIRIS (Drug) $255.38
- XYREM (Drug) $252.86
- SUNOSI (Drug) $251.36
- Vimpat (Drug) $251.27
- BOTOX THERAPEUTIC (Biological) $241.58
- APTIOM (Drug) $230.08
- Briviact (Drug) $203.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.